Evidence map›Paper›PMID 35366193›Full record

ArticleHepatology international2022

A novel machine learning-based radiomic model for diagnosing high bleeding risk esophageal varices in cirrhotic patients.

Yijie Yan, Yue Li, Chunlei Fan, Yuening Zhang, Shibin Zhang, Zhi Wang, Tehui Huang, Zhenjia Ding, Keqin Hu, Lei Li and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hepatology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yijie Yan *Department of Gastroenterology and Hepatology, Beijing You'an Hospital Affiliated With Capital Medical University, Beijing, 100069, China.
Yue Li *Department of Gastroenterology and Hepatology, Beijing You'an Hospital Affiliated With Capital Medical University, Beijing, 100069, China.
Chunlei Fan *Department of Gastroenterology and Hepatology, Beijing You'an Hospital Affiliated With Capital Medical University, Beijing, 100069, China.
Yuening ZhangDepartment of Gastroenterology and Hepatology, Beijing You'an Hospital Affiliated With Capital Medical University, Beijing, 100069, China.
Shibin ZhangDepartment of Gastroenterology and Hepatology, Beijing You'an Hospital Affiliated With Capital Medical University, Beijing, 100069, China.
Zhi WangBlot Info & Tech (Beijing) Co. Ltd, Beijing, 101200, China.
Tehui HuangBlot Info & Tech (Beijing) Co. Ltd, Beijing, 101200, China.
Zhenjia DingInstitute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
Keqin HuDivision of Gastroenterology and Hepatology, University of California, Irvine, School of Medicine, Orange, CA, USA.
Lei LiDepartment of Gastroenterology and Hepatology, Beijing You'an Hospital Affiliated With Capital Medical University, Beijing, 100069, China. 13699119545@163.com.
Huiguo DingDepartment of Gastroenterology and Hepatology, Beijing You'an Hospital Affiliated With Capital Medical University, Beijing, 100069, China. dinghuiguo@ccmu.edu.cn.ORCID http://orcid.org/0000-0002-8716-4926

Funding

Digestive Medical Coordinated Development Center of Beijing Hospitals Authority XXT24Digestive Medical Coordinated Development Center of Beijing Hospitals Authority XXZ0801Sino-German Cooperation Group GZ1517State Key Laboratory for Diagnosis and Treatment of Infectious Diseases 2017ZX10203202-004
6 · The paper itself

Abstract

BACKGROUND AND

aimTo develop and validate a novel machine learning-based radiomic model (RM) for diagnosing high bleeding risk esophageal varices (HREV) in patients with cirrhosis.

methodsA total of 796 qualified participants were enrolled. In training cohort, 218 cirrhotic patients with mild esophageal varices (EV) and 240 with HREV RM were included to training and internal validation groups. Additionally, 159 and 340 cirrhotic patients with mild EV and HREV RM, respectively, were used for external validation. Interesting regions of liver, spleen, and esophagus were labeled on the portal venous-phase enhanced CT images. RM was assessed by area under the receiver operating characteristic curves (AUROC), sensitivity, specificity, calibration and decision curve analysis (DCA).

resultsThe AUROCs for mild EV RM in training and internal validation were 0.943 and 0.732, sensitivity and specificity were 0.863, 0.773 and 0.763, 0.763, respectively. The AUROC, sensitivity, and specificity were 0.654, 0.773 and 0.632, respectively, in external validation. Interestingly, the AUROCs for HREV RM in training and internal validation were 0.983 and 0.834, sensitivity and specificity were 0.948, 0.916 and 0.977, 0.969, respectively. The related AUROC, sensitivity and specificity were 0.736, 0.690 and 0.762 in external validation. Calibration and DCA indicated RM had good performance. Compared with Baveno VI and its expanded criteria, HREV RM had a higher accuracy and net reclassification improvements that were as high as 49.0% and 32.8%.

conclusionThe present study developed a novel non-invasive RM for diagnosing HREV in cirrhotic patients with high accuracy. However, this RM still needs to be validated by a large multi-center cohort.

Indexed as

Esophageal and Gastric VaricesGastrointestinal HemorrhageHumansLiver CirrhosisMachine LearningPredictive Value of TestsROC CurveSpleenCirrhotic portal hypertensionComputed tomographyEndoscopyEsophageal varicesMachine learningRadiomic model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.